JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M101685200 on May 1, 2001

J. Biol. Chem., Vol. 276, Issue 39, 36557-36565, September 28, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/39/36557    most recent
M101685200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mani, S. S.
Right arrow Articles by Knox, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mani, S. S.
Right arrow Articles by Knox, B. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Xenopus Rhodopsin Promoter

IDENTIFICATION OF IMMEDIATE UPSTREAM SEQUENCES NECESSARY FOR HIGH LEVEL, ROD-SPECIFIC TRANSCRIPTION*

Shobana S. ManiDagger §, Suchitra BatniDagger §, Leigh WhitakerDagger , Shiming Chen||, Gustav Engbretson**Dagger Dagger , and Barry E. KnoxDagger **§§

From the Dagger  Departments of Biochemistry and Molecular Biology and ** Ophthalmology, State University of New York Upstate Medical University, Syracuse, New York 13210, the || Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110, and the Dagger Dagger  Department of Bioengineering and Neuroscience, Syracuse University, Syracuse, New York 13244

Received for publication, February 22, 2001, and in revised form, April 19, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To understand the mechanisms that control the cell-specific visual pigment gene transcription, the Xenopus rhodopsin 5' regulatory region has been characterized in vivo using transient transfection of Xenopus embryos and transgenesis. The principal control sequences were located within -233/+41, a region with significant conservation with mammalian rhodopsin genes. DNase footprinting indicated seven distinct regions that contain potential cis-acting elements. Sequences near the initiation site (-45/+41, basal region) were essential, but not sufficient, for rod-specific transcription. Two negative regulatory regions were found, one between -233 to -202, with no apparent similarity to known elements, and a second Ret-1-like CAAT (-136/-122) motif. Deletion of either sequence led to a 2-3-fold increase in expression levels, without a change in rod specificity. Sequences between -170 to -146, which contain an E-box motif, were necessary for high level expression in transgenic tadpoles but not in transient transfections. Sequences between -84 and -58, which contained an NRE-like consensus were found to be necessary for high level expression in both assays. Although expression levels were modulated by various proximal sequences in the rhodopsin promoter, none of the tested sequences were found to be necessary for rod specificity. Promoter constructs with a consensus BAT-1 sequence in conjunction with an NRE-like element upstream of the basal promoter directed low level green fluorescent protein expression in the central nervous system in transgenic tadpoles. These results suggest that rod cell-specific expression of rhodopsin is controlled by redundant elements in the proximal promoter.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Phototransduction occurs in the photoreceptor layer of the vertebrate retina, which is composed of distinct cell types: rods and cones (1). These cells express a number of specific proteins that regulate the light-dependent currents mediating vision (2, 3). Among these cell-specific proteins are the visual pigments, which combine with 11-cis-retinal to form the light-sensitive component of the transduction cascade. The visual pigments are a large family of genes, which contain rod-specific rhodopsins and at least four classes of cone-specific opsins (4). Rhodopsin, required for nocturnal vision, is the most abundant opsin in many vertebrate retinae by virtue of the size of the rod outer segments, abundance of the rod cells, and the high level of transcription. As such, the regulation of rhodopsin expression has been a focus for understanding mechanisms of cell-specific gene expression in the retina (5).

Transcription initiation has been identified as the major control point for rhodopsin gene expression (6, 7). A variety of studies using different approaches have demonstrated that important transcriptional control sequences lie within the 5' upstream regions of various rhodopsin genes. Functional assays using transgenic mice have shown that 2-4 kb1 of upstream sequences from the mouse and bovine rhodopsin genes direct reporter gene expression to the photoreceptor layer (8, 9), with sequences proximal to the initiation site (-500 and -222) being sufficient for retina-specific expression. The importance of the proximal sequences is highlighted by the high degree of homology found in this region among vertebrate rhodopsins (10). However, the immediate upstream sequences from the mammalian opsins were not able to limit expression of the reporter to rods as expected for rhodopsin (11, 12). Expression levels are also regulated by a sequence termed rhodopsin enhancer region, located ~2 kb upstream of the initiation site (13). The binding of retina-specific nuclear factors to rhodopsin upstream sequences have been localized in both proximal and distal upstream regions, suggesting a role for these elements in regulating expression (5). However, a complete description of the cis-acting elements that control transcription in rod photoreceptors is not yet available. Transcription factors that potentially regulate gene expression have been identified in the mammalian retina and several have been shown to activate rhodopsin expression in heterologous systems, e.g. Nrl (14, 15), Crx (16), and Erx (17). The mechanisms by which the different cis-acting elements in the rhodopsin upstream regions function, either independently or in concert, to produce rod-specific expression are not known.

We have used Xenopus embryos for transient transfection studies and transgenesis to investigate rod-specific transcription. Previously, we found that a 5.5-kb rhodopsin upstream fragment was transcriptionally active, driving the expression of reporter both in Xenopus embryo transfections (10) and in transgenic frogs (18). In this paper, we map the rhodopsin promoter to an upstream region spanning nucleotides -508 to +41, capable of directing reporter expression to the abundant rod cells as detected by immunolocalization and GFP expression in transgenic Xenopus rod cells. Furthermore, we have used mutational analysis and DNase footprinting to define the functional limits of the promoter to the proximal ~233 nucleotides and found multiple regulatory regions that contribute to the transcriptional activity in rod photoreceptors.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA Constructs

Upstream Fragments-- The plasmids pXOP(-5500/+41)luc and pXOP(+41/-5500)luc contain the 5.5-kb upstream sequences from the Xenopus rhodopsin gene, XOP, in the forward and reverse directions, respectively, in pGL2 vector (Promega, WI) and were constructed as described previously (10). pXOP(-1300/+41)luc was derived from pXOP(-5500/+41)luc by SacI digestion and religation of the 6.9-kb vector-containing fragment. pXOP(-503/+41)luc was derived from pXOP(-1300/+41)luc by digestion with PstI and KpnI. The resulting ends were filled-in using Klenow DNA polymerase and religated. pXOP(-503/+41)luc (5800) was generated by cloning a 5.8-kb BamHI genomic fragment containing the Xenopus rhodopsin exons and downstream sequences, into the BamHI site downstream of the luciferase gene in pXOP(-503/+41)luc.

5' Deletions-- The deletion series was constructed using exonuclease III and mung bean nuclease digestion (Stratagene). The plasmid containing a deletion of the TATA box region, pXOP(-503/-46)luc, was constructed by digestion of pXOP(-503/+41) with HindIII and subsequent religation.

Basal Region Constructs-- The TATA box region was isolated as a HindIII fragment from pXOP(-503/+41)luc and cloned into pGL2 in both orientations, pXOP(-46/+41)luc and pXOP(+41/-46)luc, as well as a dimer, pXOP(-46/+41)2luc. All deletion constructs were sequenced using the dideoxy chain termination method to confirm the sequence and orientation of inserts. For transgenic experiments, pXOP(-508/+41)GFP was generated by subcloning a PstI-BamHI fragment into pEGFP- (18).

Targeted Disruptions-- Targeted disruptions of conserved regions in the Xenopus rhodopsin promoter (-503/+41) were generated using a PCR-based approach using primers (Table I) with a PstI overhang (19). To generate the Delta (-84/-58), the PCR primer (Table I) contained a HindIII overhang, permitting direct cloning of the product into pXOP(-52/+41)luc. A second construct that disrupted -84 to -58 but maintained the spacing of the native promoter was made by cloning a synthetic oligonucleotide (5'-CTTGTACGGAGCTCTACTGTGCA-3') into the PstI site in the Delta (-84/-58) construct. PCR was performed using Ultma DNA polymerase (PerkinElmer Life Sciences). The 5' products were digested with KpnI-PstI, the 3' products were digested with PstI-BamHI, and constructs were generated by three-part ligation of KpnI-PstI product with the PstI-BamHI product. These were cloned directionally into the KpnI-BglII sites of pGL2 (Promega, WI). All mutant promoter constructs were verified by sequencing. The Delta (-136/-122) contained a single base change (G to C at -386) in addition to the intended replacement of the Ret-1 site by PstI.

                              
View this table:
[in this window]
[in a new window]
 
Table I
List of primer sequences used in generating targeted deletion and artificial constructs
The gene-specific forward primers were used in PCR reaction with GL2 3' primer (5'-CGGGATCCAAGCTT-ACCAACAGTACCGGAATGCC-3'). The gene-specific reverse primers were used in conjunction with the GL2 5' primer (5'-GGGGTACCTGTATCTTATGGTACTGTAACTGA-3').

GFP Constructs-- The XOP basal region (-52/+41) was cloned as a HindIII-BamHI fragment into complementary sites in pEGFP (-) (18) to generate EGFP-XOP basal. This plasmid was digested with KpnI and HindIII and gel-purified. Rhodopsin-targeted deletion luciferase constructs were digested with KpnI/HindIII and cloned into the KpnI-HindIII sites of pEGFP XOP basal to generate rhodopsin-targeted deletion constructs in EGFP. The Delta (-52/-38) KpnI-HindIII fragment was cloned directly into EGFP digested with the same enzymes. The clones were verified by restriction digestion and sequencing. Plasmid preparations were performed using the Qiagen protocol (Chatsworth, CA).

Basal Element Replacement Constructs-- Wild type Xenopus rhodopsin promoter luciferase construct (-503/+41) was digested with HindIII to liberate the basal region (-52/+41). The 93-bp basal region was replaced by synthetic oligonucleotides encoding Xenopus rhodopsin basal region (-52/-37) and Xenopus cardiac actin (CAR) basal region (-36/+36) or with the CMV promoter basal region (-36/+28) with HindIII linkers on either end. All constructs were confirmed by sequencing, and plasmid DNA preparations were performed using the Qiagen protocol.

Cardiac Actin Luciferase Constructs-- The cardiac actin promoter (-3270/+23; Ref. 20) was liberated as a KpnI-HindIII fragment and cloned directionally into KpnI-HindIII sites in pGL2 (Promega, WI). The clones were verified by restriction analysis and sequencing of junctions to confirm the orientations. Luciferase constructs containing Xenopus cardiac actin TATA and +1 (pCARTATA) were generated by removing the XOP (-503/-52) region from XOP-CAR using HindIII and SmaI. The ends were filled in using Klenow and religated. This construct contains XOP (-52/-37 and the cardiac actin basal region (-36/+36) driving the expression of luciferase.

Artificial Promoter Construct-- Artificial promoter was made by design of synthetic oligonucleotides (IDT, Coralville, IA). p(-96/+41)GFP contained wild type sequence of the rhodopsin proximal promoter from -96 to +41. Oligonucleotides were designed with overhanging KpnI and HindIII sites, ligated into the same sites in the XOP basal construct, and confirmed by sequencing.

Embryo Transfections

Embryos were obtained by in vitro fertilization using hormonally induced adult Xenopus females (Nasco), dejellied (21), and grown at 18-24 °C to stages 26-28 (22) in 0.1-0.2× MMR (1× MMR = 0.1 M NaCl, 2 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 5 mM HEPES, pH 7.8, and 2.5 µg/ml gentamycin), at which time the vitelline membrane was removed. Transfections were performed as described elsewhere (23). In early experiments, Lipofectin (Life Technologies, Inc.) was used; in later experiments, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-triethylammonium methylsulfate (Roche Molecular Biochemicals) were used during these studies and the amount of DNA and the DNA:lipid ratio were 6-12 µg and 1:3, respectively. DNA used for transfections were either purified by twice banding in CsCl (24) or by the Qiagen protocol. At least two different preparations were tested for each plasmid. Groupwise comparisons of mean activities (RLU/head) generated in individual transfection trials were performed using single-factor analysis of variance (alpha  = 0.05 for planned comparisons; Ref. 25). Transfection of trunks and whole embryos were done as controls. For luciferase assay, the heads (6-10) were homogenized and aliquots were assayed (using a protocol supplied by Promega) to determine the picograms of luciferase produced per well. The luciferase assay gave 50,000-100,000 relative light units/pg of purified luciferase (Sigma)/30 s using the single-channel luminometer (Berthold). Protein estimations were done using the Bradford reagent (Bio-Rad) and bovine serum albumin standards, and ranged from 10 to 20 µg/head. Luciferase activity is reported as the mean (including all trials, n given in figure legend) ± S.E.

Transgenic Xenopus

DNA was digested with XhoI to linearize the plasmid and purified after digestion (High Pure PCR Product Purification Kit, Roche Molecular Biochemicals), with final elution in water. Transgenic Xenopus embryos were produced using restriction enzyme-mediated integration as described (23). Normal embryos were selected and cultured in 0.1× MMR at 18-20 °C until approximately stage 41 (3-4 days), at which point non-mosaic green fluorescence above the weak background fluorescence from the yolk could be observed. Normal tadpoles were maintained in 0.1× MMR and used for analysis. GFP-positive transgenic tadpoles were fixed overnight in phosphate-buffered 4% paraformaldehyde. Frozen sections (10-15 µm thickness) were photographed under bright field and fluorescent lighting conditions (18). Photographic slides were scanned and figures produced using Photoshop (Adobe). The brightness and contrast of the images in sections from the various Delta  construct transgenic tadpoles were adjusted in order to visualize the cell type expressing the GFP reporter. At least three or four independent transgenic lines for each construct were sectioned and analyzed. The pattern and intensity of GFP expression between the various lines for any one construct was consistent.

DNase I Footprinting

Nuclear proteins were extracted from adult Xenopus retinae as described (26). Glutathione S-transferase-tagged bovine Crx homeodomain and flanking regions (residues 37-107, GST-CrxHD) and a hexahistidine-tagged mouse Nrl (residues 16-237, His-Nrl) were overexpressed and purified from Escherichia coli as described previously (16, 27). 32P-End-labeled DNA fragments of the Xenopus rhodopsin proximal promoter (-279/+40) was generated by PCR amplification, and footprinting reactions were carried out as described previously (16). Varying concentrations of purified transcription factors (as indicated in Fig. 2 legend) were used in the footprinting reactions. 1 µg of poly(dI-dC) was included only in the reactions containing retinal extracts.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Vertebrate Rhodopsin Upstream Sequence Comparisons-- Vertebrate rhodopsin 5'-flanking regions possess significant interspecies homology, with many short stretches of sequence identity in the 250-bp region immediately upstream of the TATA box/initiation site (Fig. 1). The overall sequence identity in this region ranged from 45% to 55% over a 200-bp stretch of sequence between Xenopus rhodopsin and other vertebrate rhodopsin sequences, suggesting a potential role for these conserved sequences in rhodopsin gene regulation. Several of the conserved regions in XOP are similar to binding sites for transcription factors in mammalian promoters: Ret4-like (-53/-38), which is a binding site for Crx (16, 28); NRE-like (-121/-110 and -84/-58), which is a binding site for a retina specific leucine zipper protein, Nrl (15, 29); the GATTA repeat (-106/-91), which is a binding site for Crx (16) and potentially Rx1; the photoreceptor cell element PCE I/Ret1 (-133/-127), found in many retina-specific genes, which is present immediately upstream of the GATTA sequence in rhodopsin genes (30, 31); and the Ret2/E box region (-158/-188) (13, 32). Such high proximal promoter sequence homology highlights a potential conservation of the mechanism regulating rhodopsin gene expression in vertebrate photoreceptors.


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 1.   Sequence similarity in rhodopsin proximal promoter region. Sequence alignments were generated using the algorithm of Needleman and Wunsch (PILEUP program, version 9, GCG) and displayed using Pretty Box, majority rules. The positions of XOP 4, XOP 3/E-box/Ret2, Ret I/PCE I, BAT1, NRE, and Ret 4 are indicated below the aligned sequences. The TATA box region and the transcriptional start site (+1) in the Xenopus rhodopsin sequence are underlined. Arrowheads denote the positions of the 5' deletion series, and the shaded boxes represent the sequences targeted for disruption. Sequences used in the comparison include Xenopus (XEN), chicken (CHK), human (HUM), bovine (BOV), rat (RAT), and mouse (MUS).

DNase Footprinting-- In order to locate binding sites for potential transcription factors, DNase footprinting was performed on the rhodopsin proximal promoter. Using an adult Xenopus retinal extract, numerous extended regions were protected from digestion, including those predicted from sequence comparisons in the proximal promoter (Fig. 2A). At present, no Xenopus homologues of Crx, Nrl, or other rod-specific transcription factors have been identified. Therefore, footprinting of the proximal promoter was done using recombinant mammalian proteins purified from E. coli: the bovine Crx homeodomain (GST-CrxHD; Ref. 16) and the DNA binding domain and surrounding bZIP regions of murine Nrl containing a hexahistidine tag (His-Nrl; Ref. 27). Both proteins protected the rhodopsin proximal region (Fig. 2, B and C). GST-CrxHD produced an extended footprint encompassing the Crx consensus sites from -153/-73 on the sense strand and -70/-156 on the antisense strand, respectively. Nrl protected a number of regions (-81/-56 on the sense strand and -57/-84 on the antisense strand) that included an AP1 consensus region and NRE, adjacent to two Crx sites. These results strongly suggest that the sequences in the Xenopus rhodopsin proximal promoter contain binding sites for members of the Otx2-related and neural retinal leucine zipper families.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 2.   DNase I footprint analysis of the Xenopus rhodopsin proximal promoter (-270/+40). A, Xenopus retinal nuclear extract. (-) indicates a reaction in which no protein was added. The reactions were performed with 10, 5, 2.5, and 1 µg of protein on the sense (+) and antisense (-) strands in the presence of 1 µg of poly d(I)·d(C). B, DNase footprinting analysis using purified GST-CrxHD. Both sense (+) and antisense (-) strand of the proximal promoter were footprinted in the absence (-) or presence of 100, 10, 1, and 0.1 ng of purified protein. C, DNase footprinting using purified His tagged mNrl. Both the sense (+) and antisense (-) strands were footprinted in the absence (-) or presence of 140, 1.4, and 0.14 ng of purified protein. The lines and positions relative to the transcriptional start site on the left indicate the major protected areas and the corresponding sites in the XOP proximal promoter are indicated on the right. Nucleotide positions were determined by comparing to a sequencing ladder run adjacent to the DNase-treated samples (data not shown).

Xenopus Rhodopsin Proximal Promoter: Analysis by Transfection of Xenopus Embryos-- A comparison of promoter activity was performed using an improved transfection protocol (23), which allows direct comparison between the mean activities observed for different DNA constructs, without normalization with a second reporter plasmid. Initial experiments were performed using three upstream fragments: (-5500/+41, -1300/+41, and -508/+41), which were all capable of driving tissue-specific expression in embryos (Table II). Comparative transfections performed at equimolar concentrations showed that the activity from the -5500/+41 fragment was ~35% lower compared with the other two promoters, which did not differ, although this difference was not significant at p < 0.05. Size of the plasmid used in the transfection appeared to have little influence on reporter gene expression, as two derivatives containing additional sequences produced similar results (Table II). One of the derivatives contained the Xenopus rhodopsin gene and 3' sequences, suggesting no significant transcriptional control regions downstream of the initiation region. Unlike that observed in heads, reporter expression from the upstream sequences in trunks was <2-fold over that obtained using GL2, which produced a relatively consistent but very low level of activity compared with heads transfected without DNA. We conclude that the major regulatory elements are located in the 508-bp proximal region.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Comparison of luciferase activity in embryos transfected with upstream regions

To further characterize the transcriptional control sequences in the proximal promoter, transgenic tadpoles were generated (18, 33) using XOP(-508/+41) driving expression of GFP. GFP expression was found only in the eye and, transiently, in the pineal. In fixed sections of transgenic retina, GFP expression was observed only in rods (see below). Each rhodopsin-positive cell also expressed GFP, with expression apparent by stage 40 (data not shown). The levels of GFP expression for the three large upstream constructs were qualitatively very similar, confirming the results from the transfections: that there is apparently no significant difference between these constructs. Taken together, these results demonstrate that the immediate upstream rhodopsin sequences direct expression to the rod cells.

Mapping the Rhodopsin Proximal Promoter-- To identify cis-acting elements in the XOP proximal promoter, a series of mutations in pXOP(-503/+41)luc were generated by either selective removal of nucleotides or by sequential DNA deletions from the 5' end (Fig. 3). The 92-bp encompassing the transcription initiation site and including the TATA region were essential for activity, as deletion of this region from the 503-bp upstream fragment decreased luciferase expression 190-fold (Fig. 3). Activity from the -503/-46 fragment was equivalent to the promoterless control. However, the 92-bp region (-46/+41) in either orientation or as a tandem repeat gave background levels of expression, indicating that these nucleotides, although necessary, were not sufficient for transcription of reporter plasmids.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Comparison of transcriptional activities from 5' deletions of the Xenopus rhodopsin promoter. Activity (RLU/embryo) from the wild type construct, -503/+41 (n = 27), various deletion constructs (n = 5-7), and GL2 (n = 8) is presented as mean ± S.E. Data were analyzed for statistical significance using single-factor analysis of variance (alpha  = 0.05). Asterisks (*) indicate activities significantly different from that of the -503/+41 fragment at p < 0.01. Double asterisks (**) indicate luciferase levels similar to promoterless control (GL2) at p < 0.01.

Analysis of luciferase activity from 5' promoter deletions identified other sequences required for promoter function. All of the deletion constructs, except XOP(-44/+41), yielded luciferase activity significantly above that obtained using GL2, in transfections of embryo heads (Fig. 3). No significant differences in luciferase activity were observed when nucleotides -508 to -234 were deleted (Fig. 3), indicating that these nucleotides do not contribute significantly to the head-specific transcription from the -503/+41 rhodopsin promoter region. Deletion of the region spanning position -233 to -203 enhanced luciferase activity 2.4-2.8-fold over that observed using any of the four larger constructs (Fig. 3). No significant changes in activity compared with -202/+41 were obtained when nucleotides -202 to -171 were deleted. A drop in activity was observed with the deletion of -170 to -145, with activity comparable to that obtained using the full fragment, -508/+41. Thus, these results are consistent with a second regulatory region from -170 to -146. A further decrease in luciferase activity (4.5-fold) compared with XOP(-145/+41) was found when -145 to -128 was deleted. A 40-fold stimulation of luciferase expression from the -127/+41 fragment relative to that obtained using XOP (-44/+41) indicated that the sequence spanning positions -127 to -46 is the smallest fragment sufficient for promoter activity.

To test for tissue specificity, embryonic trunks were transfected using the various deletion constructs and activity was compared with the corresponding activity in head by normalization to total protein. When compared with the activity measured in heads, all trunk activities except that of XOP(-127/+41) were less than 4% of the head activity. Trunk activity from all the deletion constructs was slightly elevated compared with -503/+41 and were also higher than GL2, suggesting that some nonspecific, low level transcription may occur when nucleotides -503 to -330 are deleted. However, these results show predominant head-specific expression driven by sequences further upstream of proximal promoter sequences.

To further characterize the Xenopus rhodopsin proximal promoter, targeted disruptions were created to replace putative regulatory elements with a short linker sequence (Table I). To test if the selective disruption resulted in expression in non-retinal cells, the mutant constructs were simultaneously analyzed by measuring reporter activity in transfected heads and trunks. A disruption of the region from -233 to -203 of the Xenopus rhodopsin upstream sequence (XOP 4) resulted in a 3-fold increase in reporter gene expression in heads (Fig. 4). This increase in activity in heads did not result in any significant change in reporter activity measured in transfected trunks. These observations are consistent with the increase in activity associated with the 5' deletion construct lacking the -233/-203 region. The removal of -170 to -146 (XOP 3) did not alter the expression levels in transfected heads or trunks (Fig. 4). Selective disruption of the Ret1-like core region and flanking nucleotides (-136 to -122) resulted in a 2-3-fold increase in luciferase expression in heads as compared with the wild type promoter. This increase in expression was not accompanied by any significant change in the levels of reporter expression in trunks. Alteration of one of the NRE/AP1-like sites (-120 to -109) did not significantly affect the head-specific expression of the rhodopsin promoter or lead to any change in activity in trunks. However, disruption of the second NRE-like site (-84 to -58) dramatically reduced expression (Fig. 4). This was not caused by a change in spacing since an additional construct in which the spacing of the wild type rhodopsin promoter was maintained by addition of a short insert of random sequence was also significantly lower than the -503/+41 promoter construct. These results indicate an essential role for this NRE-like element in maintenance of high level expression of rhodopsin in Xenopus rod cells. A change in either one (-98 to -91) or both (-107/-91) of the GATTA sequences caused a small reduction in expression of the transgene, 20% or 32%, respectively, that was not statistically significant. Finally, replacement of nucleotides -52 to -38, corresponding to the conserved Ret4 region in the bovine rhodopsin upstream sequence, did not change either the reporter luciferase levels or head-specific expression from the wild type promoter.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Transient transfections of Xenopus embryos with rhodopsin targeted disruption constructs. A, the proximal promoter region of Xenopus rhodopsin (-503/+41) showing the cis-acting sequences targeted for disruption with the corresponding nucleotide positions are shown. The nucleotides indicated in parentheses of each Delta 1 construct was replaced with a PstI (CTGCAG) sequence. The -84/-58 sequence in Delta 2 was replaced with TGCA or with a random sequence that maintained the spacing (Delta 3). B, the luciferase activity from embryos transfected with the various targeted disruption constructs are shown relative to the activity observed by transfection of wild type XOP (-503/+41) (n = 8). Asterisks (*) indicates activities significantly different from that of the -503/+41 fragment at p < 0.01. Double asterisks (**) indicate luciferase levels similar to promoterless control at p < 0.01.

Role of the Xenopus Rhodopsin Basal Element-- To address the contribution of the basal region in determining the specificity of expression from the Xenopus rhodopsin promoter, the sequences encoding the TATA region, initiation site, and surrounding nucleotides were tested. The XOP basal region comprising nucleotides -36/+41 was replaced by basal element regions from two non-retina-specific promoters, Xenopus cardiac actin (-36/+36; Ref. 20) and CMV (-36/+25) promoters (Fig. 5A). These basal regions do not possess any obvious sequence homology to the XOP basal region (Fig. 5B). Replacement of the XOP basal element with either cardiac actin or CMV basal region did not significantly affect the expression levels of the hybrid constructs as compared with wild type rhodopsin in transfected heads or trunks (Fig. 5C). These results show that the heterologous basal regions can functionally substitute for the XOP basal region and that the upstream cis-acting sequences are capable of controlling the cell specificity of rhodopsin expression.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Transient transfections of Xenopus embryos with XOP basal element replacement constructs. A, the basal region of the Xenopus rhodopsin proximal promoter (-36/+41) was replaced with either the corresponding basal region from Xenopus cardiac actin (XOP-CAR, -36/+36) or the CMV basal sequence (XOP-CMV, -36/+25). B, sequence comparison of the Xenopus rhodopsin, cardiac actin, and CMV promoter basal sequences show no discernible homology in the sequences replaced. The dark shaded boxes indicate the TATA region and the transcriptional start site. The sequences in the gray shaded box include the conserved Ret 4-core sequence that was included while synthesizing the XOP-CAR and XOP-CMV constructs. C, luciferase activity normalized to the wild type promoter (WT) from four to six independent transfection experiments using heads or trunks was plotted. Activity levels from the wild type cardiac actin construct and CAR and CMV promoter in heads and trunks are shown for comparison.

Transgenic Xenopus-- To investigate the cellular expression patterns from the altered rhodopsin promoters, transgenic Xenopus were generated with the various deletion constructs driving expression of GFP. Several transgenic lines were generated for each construct, and GFP expression was analyzed in tadpoles. Transgenic animals harboring deletions of (-233/-203) and (-136/-122) exhibited significant enhancement of GFP fluorescence, which was restricted to the eye. Animals transgenic for XOP promoter deletion of (-52/-38) showed GFP expression predominantly restricted to the eye, with weak fluorescence in pineal and anterior head structures in a few animals. The intensity of fluorescence in the eye was comparable to that of transgenic tadpoles generated with the wild type (-508/+41) rhodopsin construct. Deletion of -170 to -146 produced animals that exhibited much lower levels of GFP expression, which was localized to the eye. Transgenics with deletions of (-120/-109), (-98/-91) or (-107/-91) had essentially wild type expression levels. Deletions of the second NRE-like site (-84/-58) resulted in animals with extremely reduced levels of fluorescence in the eye, with expression fading to undetectable in some animals. However, the expression from these four constructs was strictly limited to the eye. To identify the cell type expressing the reporter, transverse sections of retina were analyzed by bright field and fluorescence microscopy. Within the eye, the expression of GFP from all the targeted deletion constructs was confined to the rod photoreceptor cells in the retina irrespective of the differences in fluorescence levels (Fig. 6). These experiments show that the mutant rhodopsin promoters are capable of directing rod-specific expression in vivo. This extends and confirms the observed head specificity of reporter expression in the transfection approach using the various constructs and demonstrates a redundancy in regulatory element function in targeting the expression of rhodopsin to the rod photoreceptors.


View larger version (136K):
[in this window]
[in a new window]
 
Fig. 6.   Rod-specific expression of GFP reporter in transgenic Xenopus generated with different targeted disruption constructs. Bright field images of cross sections of representative transgenic tadpoles generated using wild type (-503/+41) or targeted disruption constructs showing the pigment epithelium (PE) and different cellular layers (photoreceptors (PR), inner nuclear layer (INL) in the retina. The lens (L) and optic nerve (ON) are seen only in a few sections. Fluorescence image of the same sections show GFP expression limited to rods. Wild type section magnification, ×20; mutant magnification, ×40. In order to identify the cell type expressing GFP photographs were taken with varying exposure times, as a result fluorescence intensities do not represent actual levels of expression seen in individual tadpoles.

Artificial Promoter Constructs-- To test the role of the GATTA and NRE-like element in targeting expression to rods, an artificial promoter construct containing the -96/+41 region upstream of GFP was used to generate transgenic animals. (Fig. 7). GFP expression was seen in the eyes as well as the brain and portions of the spinal cord extending from the base of the brain to varying distances along the tail. Later in development, GFP expression became more cranially restricted and eventually faded to undetectable levels. These results suggest that the GATTA region and the NRE-like element can support reporter gene expression in the central nervous system during the early stages of development. However, high level rod-specific expression requires the presence of other sequences in the Xenopus rhodopsin proximal promoter.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 7.   The BAT 1 and NRE sequences in an artificial XOP promoter construct drives GFP expression in the developing central nervous system. A, schematic representation of an artificial promoter construct containing wild type XOP promoter sequences from -96 to +41 driving expression of the GFP reporter gene. The construct includes the 3' GATTAATA sequence of the BAT1 region (-96/-89), the NRE consensus sequence TG(N)8GC (-73/-62) denoted by boxes, and the basal promoter region (-61/+41). The sequences upstream of -96 include a short (6 bp) random linker used for cloning. B, developmental time course of GFP expression in transgenic tadpoles generated using the -96/+41 GFP construct. Transgenic tadpoles were produced and analyzed for GFP expression from 3 to 7 days post injection (dpi). Bright field and fluorescent images of tadpoles generated with -96/+41GFP (top panel) showing GFP expression in eye, brain, and spinal cord 4-7 days after injection. The background auto fluorescence from the yolk is seen in developing tadpoles injected with either -96/+41 XOP-GFP or sperm nuclei alone (nontransgenic controls, lower panels).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To study the mechanisms of rod-specific transcription in the vertebrate retina, we have focused on the analysis of the Xenopus rhodopsin promoter. Using a dual approach of embryo transfections and transgenesis, in vivo functional characterization of a rod-specific promoter has been performed in photoreceptors. This environment is permissive for photoreceptor cell-specific transcription, even though during transfection partial disruption of cell contacts prevents normal rod outer segment formation (34). The transfected heads are harvested at the onset of rhodopsin expression and photoreceptors express endogenous rhodopsin to levels similar to untreated heads at the same stage.2 The levels of luciferase with the complete promoter (-503/+41) are >100-fold higher than the promoterless control, and direct comparison between various constructs allowed us to quantitate the effects of removing individual cis-acting elements. Transgenic approaches in Xenopus have proven to be a powerful complementary approach for the analysis of cell-specific promoters (18, 33), permitting the in vivo analysis of transcription in chromatin (35, 36). In the restriction enzyme-mediated integration method, multiple copies of the plasmid integrate into random loci in the genome (18, 33). To control for potential variation due to copy number and sites of integration, independent transgenic lines were studied. Variation due to the site of integration and/or cosuppression of supernumerary copies of exogenous transgenes prevented direct comparison of expression between individual animals (37, 38). Qualitative comparison of relative expression levels for all animals made with the targeted deletion and intact GFP reporter constructs in transgenic experiments was comparable to the quantitative results found in transfection experiments with the luciferase reporter constructs, except in the case of Delta XOP 3 (see below). The pattern and temporal onset of transgene expression in native photoreceptors was reproducible among animals generated with the same construct. Therefore, transgenic animals permitted a clear morphological identification of cell-specific expression, in a retina with roughly equal numbers of rods and cones (39). The combined approaches of transient transfection and transgenic analysis permitted a detailed examination of cis-acting elements in the Xenopus opsin promoter.

We have found four cis-acting regulatory elements in the Xenopus rhodopsin proximal promoter, two of which function as positive regulatory elements and two as negative regulatory elements. The sequences between -84 and -58, which contain a match to the binding site TG(N6-8)GC(A/C/T) for Nrl (class V binding site; Ref. 27), are required for high level transcription in both transgenic animals and transfected retina. Our data suggest that these nucleotides contain an Nrl-like binding site, which in mammalian promoters is located in the same position relative to the transcriptional start site (15).

The Xenopus rhodopsin promoter contains a number of potential Otx2-like binding sites (TAAT or ATTA) between -154 to -72. A GATTA repeat, previously identified as BAT-1, shows a high degree of conservation among the opsin promoters (40) as well as other photoreceptor-specific genes (41). The BAT1 region in the bovine opsin promoter has been shown to be a binding site for HMG I(Y) (29, 42) and to contribute to the promoter activities in transfected cells, but not in in vitro transcription assays (28). Surprisingly, targeted disruption of this region in the Xenopus promoter caused no significant change in either transcriptional levels or pattern of expression (Figs. 4 and 6). Moreover, the presence of a GATTA sequence upstream of the basal promoter was not sufficient to support a high level of rod-specific expression in transgenic Xenopus (Fig. 7). The GATTA repeat may serve different functions in the different photoreceptor gene promoters. In the case of the IRBP promoter, which drives expression in both rods and cones, deletion of the GATTA element dramatically reduced transcription in transfected chick retinal cultures (43) and transgenic mice (44). In this case, the Ret-1 GAATTA site was not sufficient to overcome the mutations in the GATTA sequence. Due to the high degree of sequence conservation across species, it is tempting to propose that the GATTA region in XOP does have a functional role. Our inability to detect a significant effect in the BAT-1 mutation experiments (Figs. 4 and 6) could be explained by the presence of redundant elements in the proximal promoter.

Targeted disruption of the conserved cis-acting element, Ret-1/PCE I in the Xenopus opsin promoter resulted in a 2-fold increase in transcriptional activity in transfected retina and increased GFP expression in transgenic animals. The discrepancy between the results obtained in the 5' deletion and targeted disruptions indicates that the regulatory properties of the Ret-1 element may be determined by upstream cis-acting sequences, perhaps through interactions with transcription factors bound to these elements. This supports our results obtained using synthetic promoter constructs, containing one or more copies of the Ret-1 region (-144 to -120) upstream of the rhodopsin basal region (-51/+41), which contribute to 0.1% or less of the Xenopus rhodopsin promoter's transcriptional activity in transient transfections (data not shown). Several proteins have been shown to bind to the Ret-1/PCE I sequence including Crx (16), Rx (31), and Erx (17), each of which functions as a weak transcriptional activator in transfection assays. However, these proteins most likely interact with other retinal transcription factors, as seen in the case of a direct interaction between Nrl and Crx (16, 45), resulting in synergistic activation of the bovine opsin promoter. It is unclear if the spacing of the Ret-1 sequence relative to the transcriptional start site affects its regulatory role. The targeted disruptions may have resulted in a promoter conformation more favorable to the assembly of transcription factors, thereby stimulating the transcriptional activity.

The region between -170 to -146 (XOP 3) and -233 and -203 (XOP 4) contains sequences that were footprinted with adult Xenopus nuclear extracts (Fig. 2A). In retinal transfections, deletion of -233 to -203 caused a 3-fold increase in transcription that was also seen in transgenic animals, suggesting that this region contains a negative regulatory element. The sequences in the XOP 4 region do not possess any sequence similarity to the mammalian opsin promoters or a recognizable consensus transcription factor binding site. Although there is evidence for a negative regulatory region in mammalian opsin promoters, the sequences do not share any similarity with XOP 4. There is limited sequence similarity between the Xenopus and mammalian promoters in the XOP 3, only encompassing an E-box motif, CANNTG at nucleotide -163 to -158. In the mouse opsin promoter, the equivalent E-box sequences were shown to bind MASH-1 using mobility shift assays (46). The Xenopus homologues of MASH proteins (XASH-1 and XASH-3) are only expressed in the ciliary margins in the laminated retina (47) and not in the photoreceptors. Therefore, if XOP 3 function is regulated by its conserved E-box motif, then either a different class of bHLH proteins bind to this region in the Xenopus opsin promoter, or the effect of XOP 3 on opsin expression is exerted at a step prior to photoreceptor differentiation. Targeted disruption of these sequences, however, showed no change in transfected retina but greatly reduced levels of reporter expression in transgenic animals. The discrepancy between the two assays for this construct suggests that protein binding to XOP 3 deletion may be sensitive to the chromatin environment or the proteins that bind to XOP 3 may be part of the chromatin-remodeling complex. This region contains an AT-rich sequences (at least five consecutive A/T at -152 to -147). Further experiments are needed to determine if HMG I(Y) actually binds to the Xenopus proximal promoter and activates transcription via any of these sequences.

    ACKNOWLEDGEMENTS

We thank S. Moody and M. Pierce for helpful suggestions, C. Schlueter and M. Ji for assistance in making some of the transgenic Xenopus, T. Kerppola for providing the purified mNrl protein, and R. Barlow for support and encouragement during these studies.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants EY09409, EY11256, and EY12975 (all to B. E. K.), National Institutes of Health Grant EY00667 (to R. B.), and a grant from the Research to Prevent Blindness Foundation and the Lion's Club of Central New York.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

Present address: CLONTECH Laboratories, Palo Alto, CA, 94303-4230.

§§ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, SUNY Upstate Medical University, 750. E. Adams St., Syracuse, NY 13210. Tel.: 315-464-8719; Fax: 315-464-8750; E-mail: knoxb@mail.upstate.edu.

Published, JBC Papers in Press, May 1, 2001, DOI 10.1074/jbc.M101685200

2 S. S. Mani, S. Batni, L. Whitaker, S. Chen, G. Engbretson, and B. E. Knox, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: kb, kilobase pair(s); bp, base pair(s); XOP, Xenopus rhodopsin gene; RLU, relative light unit(s); luc, luciferase; GFP, green fluorescent protein; Nrl, neural retinal leucine zipper transcription factor; Crx, Cone-rod homeobox transcription factor, Erx, Empty spiracles-related homeobox, Rx, Pax6-related homeobox; CMV, cytomegalovirus; PCR, polymerase chain reaction; EGFP, enhanced green fluorescent protein; CAR, cardiac actin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Dowling, J. E. (1987) The Retina: An Approachable Part of the Brain , pp. 12-41, Harvard University Press, Cambridge, MA
2. Hargrave, P. A., and McDowell, J. H. (1992) FASEB J. 6, 2323-2331
3. Yarfitz, S., and Hurley, J. B. (1994) J. Biol. Chem. 269, 14329-14332
4. Yokoyama, S. (1996) Genes Cells 1, 787-794
5. Kumar, R., and Zack, D. J. (1995) in Molecular Genetics of Ocular Diseases (Wiggs, J. L., ed) , pp. 139-160, Wiley-Liss, Inc., New York
6. Treisman, J. E., Morabito, M. A., and Barnstable, C. J. (1988) Mol. Cell. Biol. 8, 1570-1579
7. DesJardin, L. E., Timmers, A. M., and Hauswirth, W. W. (1993) J. Biol. Chem. 268, 6953-6960
8. Lem, J., Applebury, M. L., Falk, J. D., Flannery, J. G., and Simon, M. I. (1991) Neuron 6, 201-210
9. Zack, D. J., Bennett, J., Wang, Y., Davenport, C., Klaunberg, B., Gearhart, J., and Nathans, J. (1991) Neuron 6, 187-199
10. Batni, S., Scalzetti, L., Moody, S. A., and Knox, B. E. (1996) J. Biol. Chem. 271, 3179-3186
11. Gouras, P., Kjeldbye, H., and Zack, D. J. (1994) Visual Neurosci. 11, 1227-1231
12. Woodford, B. J., Chen, J., and Simon, M. I. (1994) Exp. Eye Res. 58, 631-635
13. Nie, Z., Chen, S., Kumar, R., and Zack, D. J. (1996) J. Biol. Chem. 271, 2667-2675
14. Swaroop, A., Xu, J. Z., Pawar, H., Jackson, A., Skolnick, C., and Agarwal, N. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 266-270
15. Rehemtulla, A., Warwar, R., Kumar, R., Ji, X., Zack, D. J., and Swaroop, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 191-5
16. Chen, S., Wang, Q. L., Nie, Z., Sun, H., Lennon, G., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Zack, D. J. (1997) Neuron 19, 1017-1030
17. Martinez, J. A., and Barnstable, C. J. (1998) Biochem. Biophys. Res. Commun. 250, 175-180
18. Knox, B. E., Schlueter, C., Sanger, B. M., Green, C. B., and Besharse, J. C. (1998) FEBS Lett. 423, 117-121
19. Tomic-Canic, M., Sunjevaric, I., and Blumenberg, M. (1996) Meth. Mol. Biol. 57, 259-267
20. Mohun, T. J., Taylor, M. V., Garrett, N., and Gurdon, J. B. (1989) EMBO J. 8, 1153-1161
21. Newport, J. W., and Kirschner, M. W. (1984) Cell 37, 731-742
22. Nieuwkoop, P., and Faber, P. (1967) Normal Table of Xenopus laevis , pp. 162-189, North Holland Publishing, Amsterdam
23. Batni, S., Mani, S. S., Schlueter, C., Ji, M., and Knox, B. E. (2000) Methods Enzymol. 316, 50-64
24. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1992) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
25. Sokal, R. R., and Rohlf, F. J. (1995) Biometry , 3rd Ed. , pp. 229-260, W. H. Freeman and Co., New York
26. Andrews, N. C., and Faller, D. V. (1991) Nucleic Acids Res. 19, 2499
27. Kerppola, T. K., and Curran, T. (1994) Oncogene 9, 675-684
28. Chen, S., and Zack, D. J. (1996) J. Biol. Chem. 271, 28549-28557
29. Kumar, R., Chen, S., Scheurer, D., Wang, Q. L., Duh, E., Sung, C. H., Rehemtulla, A., Swaroop, A., Adler, R., and Zack, D. J. (1996) J. Biol. Chem. 271, 29612-29618
30. Kikuchi, T., Raju, K., Breitman, M. L., and Shinohara, T. (1993) Mol. Cell. Biol. 13, 4400-4408
31. Kimura, A., Singh, D., Wawrousek, E. F., Kikuchi, M., Nakamura, M., and Shinohara, T. (2000) J. Biol. Chem. 275, 1152-1160
32. Yu, X., Chung, M., Morabito, M. A., and Barnstable, C. J. (1993) Biochem. Biophys. Res. Commun. 191, 76-82
33. Kroll, K. L., and Amaya, E. (1996) Development 122, 3173-3183
34. Stiemke, M. M., Landers, R. A., al-Ubaidi, M. R., Rayborn, M. E., and Hollyfield, J. G. (1994) Dev. Biol. 162, 169-180
35. Wolffe, A. P. (1994) Cell 77, 13-16
36. Struhl, K. (1996) Cell 84, 179-182
37. Pal-Bhadra, M., Bhadra, U., and Birchler, J. A. (1997) Cell 90, 479-490
38. Bingham, P. M. (1997) Cell 90, 385-387
39. Saxen, L. (1954) Ann. Acad. Sci. Fenn. A 23, 1-95
40. DesJardin, L. E., and Hauswirth, W. W. (1996) Invest. Ophthalmol. Vis. Sci. 37, 154-165
41. Bobola, N., Briata, P., Ilengo, C., Rosatto, N., Craft, C., Corte, G., and Ravazzolo, R. (1999) Mech. Dev. 82, 165-169
42. Chau, K. Y., Munshi, N., Keane-Myers, A., Cheung-Chau, K. W., Tai, A. K., Manfioletti, G., Dorey, C. K., Thanos, D., Zack, D. J., and Ono, S. J. (2000) J. Neurosci. 20, 7317-7324
43. Boatright, J. H., Buono, R., Bruno, J., Lang, R. K., Si, J. S., Shinohara, T., Peoples, J. W., and Nickerson, J. M. (1997) Exp. Eye Res. 64, 269-277
44. Bobola, N., Hirsch, E., Albini, A., Altruda, F., Noonan, D., and Ravazzolo, R. (1995) J. Biol. Chem. 270, 1289-1294
45. Mitton, K. P., Swain, P. K., Chen, S., Xu, S., Zack, D. J., and Swaroop, A. (2000) J. Biol. Chem. 275, 29794-29799
46. Ahmad, I. (1995) Brain Res. Dev. Brain Res. 90, 184-189
47. Perron, M., and Harris, W. (1999) in Cell Lineage and Fate Determination (Moody, S., ed) , pp. 353-365, Academic Press, San Diego, CA


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This